James Chambers to Antineoplastic Agents
This is a "connection" page, showing publications James Chambers has written about Antineoplastic Agents.
Connection Strength
0.284
-
Maniwang JRC, Tang Y, Desamero MJM, Wang C, Fujii W, Eer D, Kyuwa S, Chambers JK, Uchida K, Kominami Y, Ushio H, Cervancia CR, Estacio MAC, Kakuta S. Stingless bee propolis promotes hair follicle regeneration and melanocyte function in chemotherapy-induced alopecia mouse model. Exp Anim. 2026 Apr 22; 75(2):156-171.
Score: 0.129
-
Yokota S, Fujii W, Motegi T, Komori M, Nishi R, Chambers JK, Uchida K, Yonezawa T, Momoi Y, Maeda S. Sorafenib inhibits myeloid-derived suppressor cell infiltration in canine transitional cell carcinoma. Vet Immunol Immunopathol. 2025 Dec; 290:111019.
Score: 0.128
-
Eto S, Saeki K, Yoshitake R, Yoshimoto S, Shinada M, Ikeda N, Kamoto S, Tanaka Y, Kato D, Maeda S, Tsuboi M, Chambers J, Uchida K, Nishimura R, Nakagawa T. Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells. PLoS One. 2019; 14(6):e0218382.
Score: 0.021
-
Moore DJ, Chambers JK, Murdock PR, Emson PC. Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor. Neuropharmacology. 2002 Nov; 43(6):966-78.
Score: 0.007